DexCom, headquartered in San Diego, develops glucose monitoring systems for diabetes management, employing 9,600 people since its IPO in 2005. Its products include the Dexcom G6 and G7 continuous glucose monitoring systems.
DXCM has been in the news recently: Wall Street experienced positive momentum, with the S&P 500 rising 1% to 5,560, marking its eighth consecutive gain since November 2023. This upward trend in U.S. stocks indicates strong market performance, with the index on track for its ninth straight day of gains, the longest streak since May 2024.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!